AADAC Antikörper (C-Term)
Kurzübersicht für AADAC Antikörper (C-Term) (ABIN452700)
Target
Alle AADAC Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- This antibody detects Arylacetamide deacetylase at C-term.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human
-
Aufreinigung
- Prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS
-
Immunogen
- KLH conjugated synthetic peptide selected from the C-terminal region of human AADAC
-
-
-
-
Applikationshinweise
-
ELISA: 1: 1,000. Western blot: 1: 50 - 1: 100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.52 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C.
-
-
- AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))
-
Andere Bezeichnung
- AADAC
-
Hintergrund
- Microsomal arylacetamide deacetylase (AADAC) competes against the activity of cytosolic arylamine N-acetyltransferase which catalyzes the N-or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens. Arylacetamide deacetylation by AADAC is also important in the metabolic activation of some arylamine substrates to carcinogens.Synonyms: CES5A1, DAC, arylacetamide deacetylase
-
Gen-ID
- 13
-
NCBI Accession
- NP_001077
-
UniProt
- P22760
Target
-